Off-label Reprint Distribution Outside Of FDAMA Is Legal, FDA Tells Court

Off-label drug use promotions would be prohibited by FDA only if they expressly violate an agreement struck between the agency and a firm under the FDA Modernization Act, FDA attorneys told a three-judge panel of the Washington D.C. federal appellate court reviewing Washington Legal Foundation v. Henney.